Patients diagnosed with breast cancer, head and neck cancer, and malignant melanoma are particularly at risk for disorders such as anxiety or depression.
Researchers at the Arizona State University Biodesign Institute can developed a new method of early disease detection.
The American Society of Clinical Oncology has released a nearly 100-page report detailing the year's most significant developments in cancer.
Researchers looking at multiple different levels of changes in renal cell carcinoma are closer to determining how these tumors grow and survive.
Adding three-dimensional breast imaging to standard digital mammography increases diagnostic accuracy and reduces false-positive recall rates.
Inhibiting one protein eliminated metastasis of melanoma in lab studies, a finding that could lead to targeted therapies for a range of cancers.
Black women have the highest death rate from breast cancer of all racial and ethnic groups, and are 40% more likely to die of the disease than are white women, according to a new report from the CDC.
It may be reasonable to use methods other than colonoscopy to rescreen people who had negative results on their first screening colonoscopy.
Many persons who receive chemotherapy for incurable cancers may not understand that the treatment is unlikely to be curative.
Assessing how water moves through breast tissue may reduce false-positive findings among women undergoing dynamic contrast-enhanced MRI.
A simple three-question survey has been developed to help clinicians identify women who may be experiencing symptoms of ovarian cancer.
The quality of breast cancer surgery improved when percutaneous needle biopsy was performed preoperatively.
Earlier study findings that anthracycline- or trastuzumab-based treatment for breast cancer raises the risk for heart failure and cardiomyopathy can be extended to a more general population of women.
Among patients with colorectal cancer, 29% in a nationally representative sample were diagnosed after an emergency, such as an obstruction or perforation of the bowel.
Compared with prostatectomy, surveillance will likely reduce prostate cancer-specific survival only slightly and greatly enhance quality of life.
The somo-V Automated Breast Ultrasound System received FDA approval for use in combination with standard mammography in women with dense breast tissue.
Dividing bowel preparation solution into two doses resulted in better preparation quality, detection rates, and colonoscopy completion rates.
For female patients with an abnormal breast or cervical cancer screening result, patient navigation services help to decrease the time to diagnosis and helps vulnerable populations get the care they need in a timely manner.
Human papillomavirus (HPV) positivity alone is a poor biomarker for HPV-driven head and neck cancers, according to two recent studies.
An analysis of breath samples from patients with pulmonary nodules distinguished benign from malignant growths in a recent study.
One year after men undergo surgical removal of prostate cancer, they have significant anxiety, which appears to be linked to poor sexual satisfaction and depression.
Flow cytometry has been identified as better for checking for minimal residual disease than two other widely used methods to predict patient survival.
Overweight and obese women with hormone receptor (HR)-positive operable breast cancer have an increased risk of disease recurrence and death.
Persons with more than one glioblastoma tumor upon diagnosis experience significantly worse survival than do patients with a solitary lesion.
A lung cancer risk-prediction model effectively identified individuals who would benefit most from low-dose computed tomography (CT) screening.
Overall survival rates have improved for men with prostate cancer following the introduction of PSA screening, particularly for African Americans.
The magnitude of change in serum prostate-specific antigen (PSA) after 5α-reductase inhibitor therapy may be useful in diagnosing prostate cancer.
Because people who have had multiple bouts of basal cell carcinoma always risk recurrence, the disease can be considered chronic for such patients.
Good endoscopic equipment, endoscopic surgery, and good tissue samples are key to diagnosing and managing esophageal conditions.
News about pertuzumab injection (Perjeta); ondansetron (Zofran); carfilzomib (Kyprolis); Therascreen KRAS RGQ PCR Kit; Prostate Health Index (phi); and Prepopik
Sign Up for Free e-newsletters
- FDA: Number of U.S. Women With Breast Implant-Caused Cancer Has Increased
- NIH Establishes Educational Program on Genomics, Genetics for Oncology Nurses
- Immunotherapy for HER2-positive Breast Cancer: Recent Advances and Combination Therapeutic Approaches
- A Review of Clinical Outcomes in Patients With Early-Stage Burkitt Lymphoma
- USPSTF Still Recommends Against Pancreatic Cancer Screening
- Oncology Nurse Navigation Facilitates Timely Treatment of Pancreatic Cancer
- Oncology Nurses Weigh In on Their Patient-Centered Communication Practices, Needs
- Substitute for Lidocaine
- CART cell therapy for prostate cancer: status and promise
- Shifting Dynamics of Social Support After a Cancer Diagnosis
- Survey Demonstrates Implicit Bias Toward Cervical Cancer Diagnoses Among Nurses, Women
- Use of Watchful Waiting Up for Low-Risk Localized Prostate Cancer
- Sharing Personal Contact Information With Patients
- Country-Specific Norms Created for Cancer-Related Quality of Life
- Nurse-Led vs Oncologist-Led Breast Cancer Follow-up Program: Early Feasibility Results of an Ongoing Study
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|